Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 6/20 | 0.35 |
| ▸ | TK1 | P04183 | 4/20 | 0.34 |
| ▸ | TK2 | O00142 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.32 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19565366 | 0.83 | TOP2A (0.32) | TOP2ATK2 | |
| SCHEMBL17231013 | 0.80 | RNASE1 (0.39) | TK1TK2RNASE1 | |
| SCHEMBL19565363 | 0.80 | CA12 (0.35) | TK1TK2POLBRNASE1 | |
| SCHEMBL17231062 | 0.78 | TYMS (0.37) | POLB | |
| SCHEMBL17231081 | 0.78 | TYMS (0.37) | POLB | |
| SCHEMBL17231011 | 0.76 | RNASE1 (0.34) | POLBRNASE1 | |
| SCHEMBL18848628 | 0.69 | POLB (0.55) | TK1TK2POLBRNASE1 | |
| SCHEMBL10079072 | 0.69 | TOP2A (0.54) | TOP2ATK1RNASE1 | |
| SCHEMBL14788961 | 0.69 | TOP2A (0.54) | TOP2ATK1RNASE1 | |
| SCHEMBL889593 | 0.69 | TOP2A (0.54) | TOP2ATK1RNASE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170320904-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | AJINOMOTO CO., INC. (JP) | 2017-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320904-A1 | PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED | SP1, MED25, CTCF | TOP2A 1010/4885TK1 1519/4885TK2 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.